Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar 25;17(3):e81180.
doi: 10.7759/cureus.81180. eCollection 2025 Mar.

Investigating the Challenges in Diagnosis and Management of Giant Cell Tumors in the Distal Phalanx: A Case Report

Affiliations
Case Reports

Investigating the Challenges in Diagnosis and Management of Giant Cell Tumors in the Distal Phalanx: A Case Report

Jason S DeFrancisis et al. Cureus. .

Abstract

Giant cell tumors (GCTs) of bone are locally aggressive neoplasms that typically occur in the distal femur or proximal tibia. Infrequently, they may develop in the bones of the hand, including the distal phalanx. This case highlights the importance of a thorough and systematic diagnostic workup of GCTs presenting in rare and challenging locations such as the distal phalanx. A 53-year-old male presented to the clinic with a several-month history of left middle fingertip enlargement, pain, and limited mobility. Plain film X-ray and magnetic resonance imaging revealed a lesion in the left middle distal phalanx. The patient underwent curettage with a working diagnosis of giant cell reparative granuloma with focal fracture callus. Eight months later the mass recurred and amputation of the distal phalanx tip was performed. The histopathological evaluation confirmed a diagnosis of a giant cell tumor of bone. The postoperative course was unremarkable. No further treatment was required. In rare and difficult-to-diagnose tumors clinicians should consult with experienced pathologists to improve diagnostic accuracy. This approach is essential for optimizing patient outcomes, preventing treatment delays, and reducing the risk of adverse events.

Keywords: amputation; consultation; curettage; distal phalanx; giant cell reparative granuloma; giant cell tumor of bone; orthopedic hand surgery; orthopedic surgery.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. A) A posteroanterior and B) lateral radiograph of the left hand demonstrating an erosive lesion at the fingertip involving the tuft of the distal phalanx of the middle finger.
Figure 2
Figure 2. A) Sagittal T1 MRI of the left third distal phalanx, demonstrating an intraosseous mass of the distal phalanx that does not extend into the joint space.
B) Sagittal T1 fat sat post-contrast MRI of the left third distal phalanx, demonstrating a solid enhancing lesion.
Figure 3
Figure 3. A) Coronal STIR MRI of the left third distal phalanx, demonstrating an intraosseous mass with an expansile bulbous appearance at the tuft.
B) Coronal T1 MRI of the left third distal phalanx, revealing no edema within the mass and the adjacent normal bone. STIR: Short tau inversion recovery
Figure 4
Figure 4. A) Axial T1 fat sat MRI of the left third distal phalanx demonstrating a solid lesion.
B) Axial T1 fat sat post-contrast MRI of the left third distal phalanx of the distal phalanx, demonstrating a solid enhancing lesion.
Figure 5
Figure 5. A) Micrographs of the lesion (H&E 40×), composed of an abundance of multinucleated osteoclast-like giant cells.
Osteoclast-like giant cells display mitosis. The white arrow shows a multinucleated giant cell. The black arrow displays a mononuclear stromal cell. B) Zoomed-in micrograph of the lesion (H&E), displaying osteoclast-like giant cells. The white arrow shows a multinucleated giant cell. The white arrowheads point to individual nuclei within the multinucleated giant cell. (Imaging of the gross specimen was not able to be obtained but was described as consisting of multiple fragments of pink, soft tan tissue with a measurement of 1.0 × 0.7 × 0.4 cm).

Similar articles

References

    1. Amini B, MacManus D, Le L, et al. Giant cell tumor of bone. [ Mar; 2025 ]. 2025. https://doi.org/10.53347/rID-1385 https://doi.org/10.53347/rID-1385
    1. Regional variation and challenges in estimating the incidence of giant cell tumor of bone. Liede A, Bach BA, Stryker S, Hernandez RK, Sobocki P, Bennett B, Wong SS. J Bone Joint Surg Am. 2014;96:1999–2007. - PubMed
    1. Giant cell tumor of bone: Review, mimics, and new developments in treatment. Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR Jr. Radiographics. 2013;33:197–211. - PubMed
    1. Giant cell tumor of bone - An overview. Sobti A, Agrawal P, Agarwala S, Agarwal M. https://pmc.ncbi.nlm.nih.gov/articles/PMC4733230/ Arch Bone Jt Surg. 2016;4:2–9. - PMC - PubMed
    1. Giant cell tumour of bone: Morphological, biological and histogenetical aspects. Werner M. Int Orthop. 2006;30:484–489. - PMC - PubMed

Publication types

LinkOut - more resources